Ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis against HIV infection, identifies patterns of medication taking that may lead to risk of prophylactic failure in near real-time. - EurekAlert

Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis to prevent HIV infection (PrEP), can reveal patt…

Friday,  May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure… [+1540 chars]

full article...